Association Between Endocrine Therapy and Fracture Risk in Women with Breast Cancer in Germany—A Retrospective Cohort Study
Background: Aromatase inhibitors (AIs) are widely used in hormone receptor-positive breast cancer but may adversely affect bone health. Evidence on their independent association with fracture risk compared with tamoxifen (TAM) remains inconsistent. Methods: In this retrospective cohort study, women...
محفوظ في:
| المؤلفون الرئيسيون: | , , , |
|---|---|
| التنسيق: | Artigo |
| اللغة: | Inglês |
| منشور في: |
MDPI AG
2026-05-01
|
| سلاسل: | Current Oncology |
| الموضوعات: | |
| الوصول للمادة أونلاين: | https://www.mdpi.com/1718-7729/33/6/322 |
| الوسوم: |
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|